UC San Diego Health Sciences schools, institutes and centers are at the forefront of discovery and transformation.
UC San Diego has once again been recognized among the top institutions in the world on the 2025 Highly Cited Researchers list compiled by Clarivate. UC San Diego tied for 18th in the world this year with UCLA. Both schools have 50 recognitions on the Highly Cited Researchers listing.
UC San Diego researchers have developed a new targeted therapy for triple-negative breast cancer, the most difficult-to-treat subtype of the disease.
A UC San Diego study suggests that the depiction of lorazepam use on Season 3 of The White Lotus TV series sparked 1.6 million extra Google searches for information about the benzodiazepine drug, including how to acquire it online.
UC San Diego has appointed Rohit Loomba, M.D., as inaugural holder of the John C. Martin Endowed Chair in Liver Disease, which was created to support innovative research and treatment in liver disease.
Clara Bard, 619-363-5115, scbard@ucsd.edu
In an analysis of more than 6,800 colon cancer patients across all University of California Health sites, researchers found that those taking glucagon-like peptide-1 (GLP-1) medications were less than half as likely to die within five years compared to those who weren’t on the drugs (15.5% vs. 37.1%
Washington Post, November 9
New York Times, September 23
Forbes, September 8
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
